agilon health, inc. 2025-2026 Proxy Voting Records

Description as filed by funds: Election of Class II Directors: Diana McKenzie

agilon health, inc.’s own tally for this item (“Elect Director: Diana McKenzie”): 11,679,958 for, 177,760 against, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 1 - Election of Directors The following three individuals were elected to the Company's Board of Directors to serve as Class II directors until the Company's 2029 annual meeting of stockholders and until their successors have been duly elected and qualified.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 48 asset managers below reported 2,946,368 for, 11,919 against, 1,266 abstained.

Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.

Description as filed by funds: Election of Class II Directors: Karen McLoughlin

agilon health, inc.’s own tally for this item (“Elect Director: Karen McLoughlin”): 9,525,491 for, 2,332,208 against, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 1 - Election of Directors The following three individuals were elected to the Company's Board of Directors to serve as Class II directors until the Company's 2029 annual meeting of stockholders and until their successors have been duly elected and qualified.”
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 48 asset managers below reported 2,708,429 for, 249,858 against, 1,266 abstained.

Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.

Description as filed by funds: Election of Class II Directors: Ronald Williams

agilon health, inc.’s own tally for this item (“Elect Director: Ronald Williams”): 10,837,623 for, 1,019,347 against, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 1 - Election of Directors The following three individuals were elected to the Company's Board of Directors to serve as Class II directors until the Company's 2029 annual meeting of stockholders and until their successors have been duly elected and qualified.”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 48 asset managers below reported 2,543,472 for, 414,815 against, 1,267 abstained.

Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.

Description as filed by funds: Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock by a ratio of one-for-five to one-for-twenty-five, with the exact ratio to be set within this range by the Board of Directors in its sole discretion (without reducing the authorized number of shares of the Company's common stock) (the "Amendment Proposal"); and

agilon health, inc.’s own tally for this item (“1. Approval of Reverse Stock Split”): 356,574,789 for, 6,187,388 against — passed, per its Form 8-K filed March 18, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 1 - Approval of Reverse Stock Split The stockholders approved an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock by a ratio of one-for-five to one-for-twenty-five (the "Reverse Stock Split"), wit…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 43 asset managers below reported 77,805,469 for, 4 against, 31,549 abstained.

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

Description as filed by funds: APPROVAL OF THE ADJOURNMENT OF THE SPECIAL MEETING TO A LATER DATE OR DATES, IF NECESSARY, TO PERMIT FURTHER SOLICITATION AND VOTE OF PROXIES IN THE EVENT THERE ARE NOT SUFFICIENT VOTES IN FAVOR OF THE AMENDMENT PROPOSAL.

agilon health, inc.’s own tally for this item (“2. Approval of Adjournment of the Special Meeting”): 350,802,135 for, 11,672,713 against — passed, per its Form 8-K filed March 18, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 2 - Approval of Adjournment of the Special Meeting The stockholders approved the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Amendment Proposal.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 43 asset managers below reported 78,050,499 for, 401,726 against, 31,549 abstained.

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

Description as filed by funds: Approval, by advisory vote, of the compensation paid to the Company's named executive officers.

agilon health, inc.’s own tally for this item (“3. Non-Binding Vote on Executive Compensation”): 11,228,258 for, 627,870 against — passed, per its Form 8-K filed June 3, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 3 - Non-Binding Vote on Executive Compensation The stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company's named executive officers.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 47 managers: 2,569,529 for, 388,758 against, 1,267 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 103 managers: 9,710,479 for, 491,598 against, 251,695 abstained. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2026.

agilon health, inc.’s own tally for this item (“2. Ratification of Independent Registered Public Accounting Firm”): 13,712,368 for, 6,616 against — passed, per its Form 8-K filed June 3, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 2 - Ratification of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 48 asset managers below reported 2,958,283 for, 4 against, 1,266 abstained.

Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.